Page last updated: 2024-08-24

3-iodobenzylguanidine and Bradykinesia

3-iodobenzylguanidine has been researched along with Bradykinesia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, SK; Chung, EJ; Kim, EG; Kim, MS; Kim, SJ; Oh, M; Oh, SJ; Seog, DH1
Chiaravalloti, A; Danieli, R; Di Biagio, D; Di Pietro, B; Olivola, E; Pierantozzi, M; Schillaci, O; Simonetti, G; Stampanoni, M; Stanzione, P; Stefani, A; Tavolozza, M1
Hashimoto, M; Oka, H; Suzuki, M; Taira, K; Urashima, M1

Other Studies

3 other study(ies) available for 3-iodobenzylguanidine and Bradykinesia

ArticleYear
Differences in myocardial sympathetic degeneration and the clinical features of the subtypes of Parkinson's disease.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2011, Volume: 18, Issue:7

    Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Female; Humans; Hypokinesia; Male; Middle Aged; Muscle Rigidity; Myocardium; Nerve Degeneration; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tremor

2011
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG.
    Molecular medicine reports, 2012, Volume: 6, Issue:6

    Topics: 3-Iodobenzylguanidine; Age Factors; Aged; Female; Heart; Humans; Hypokinesia; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Sympathectomy; Tremor

2012
Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease.
    Neuroreport, 2007, Nov-19, Volume: 18, Issue:17

    Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Heart; Humans; Hypokinesia; Male; Mediastinum; Middle Aged; Myocardium; Parkinson Disease; Phenotype; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis

2007